Abstract:Purpose: Traumatic spinal cord injury (TSCI) induces a powerful inflammatory response that can significantly exacerbate the extent and severity of neural damage (termed as "secondary injury"). Thus, the suppression of inflammation is crucial for reducing neurological dysfunction following TSCI. However, the conventional anti-inflammatory drugs show limited efficacy because of poor penetration and release kinetics at the injury site. This study describes the design, synthesis, release kinetics, biosafety, and preclinical efficacy of mino-cycline (MC)-loaded poly(alpha-lipoic acid)-methylprednisolone (P alpha LA-MP) prodrug nanopartides (NPs) for the combined anti-inflammatory treatment of TSCI. Methods: NPs were produced by conjugating MP to P alpha LA and then loading MC. The NP structure was confirmed through H-1 nuclear magnetic resonance (H-1 NMR), Fourier transform infrared spectroscopy, ultraviolet-visible absorption spectroscopy, gel permeation chromatography, dynamic light scattering, and transmission electron microscopy. Drug-loading content and efficacy were measured using high-performance liquid chromatography (HPLC) or H-1 NMR and release kinetics through HPLC. Biosafety was examined using the MTT assay, cell penetration efficiency using confocal microscopy, and flow cytometry using Cyanine5 (Cy5)-labeled MC-P alpha LA-MP NPs, effects on injury-induced pro-inflammatory cytokine release using enzyme-linked immunosorbent assays and immunofluorescence, and treatment efficacy by measuring motor recovery in a rat model of TSCI. Results: The MC-P alpha LA-MP NPs exhibited high biocompatibility and released 81% MC and 54% MP within 24 h under TSCI-like conditions, effectively reducing 40% of pro-inflammatory cytokine release both in cultures and injured rat spinal cord tissues. Systemic injection increased the Basso, Beattie, Bresnahan score of TSCI rats from 2.33 +/- 0.52 to 8.83 +/- 1.83 in 8 weeks, providing effective neuroprotection and enhanced exercise recovery in the TSCI rats. Conclusion: The MC-P alpha LA-MP NPs can mitigate secondary inflammation and preserve motor function following experimental TSCI, which suggests their potential for clinical application.

Neuroprotective macromolecular methylprednisolone prodrug nanomedicine prevents glucocorticoid-induced muscle atrophy and osteoporosis in a rat model of spinal cord injury

Targeted-delivery of nanomedicine-enabled methylprednisolone to injured spinal cord promotes neuroprotection and functional recovery after acute spinal cord injury in rats

An Injectable Recombinant Human Milk Fat Globule Epidermal Growth Factor 8 Loaded Copolymer System for Spinal Cord Injury Reduces Inflammation Through NF-B and Neuronal Cell Death

The administration of high-dose methylprednisolone for 24 h reduced muscle size and increased atrophy-related gene expression in spinal cord-injured rats

Local Administration of Methylated Prednisolone Comprising Solid Lipid Nanoparticles Improves Post Traumatic Spinal Cord Injury

Methylprednisolone Promotes Recovery of Neurological Function after Spinal Cord Injury: Association with Wnt/β-catenin Signaling Pathway Activation.

Macrophage membrane-modified reactive oxygen species-responsive prodrug self-assembled nanoparticles for the targeted treatment of traumatic spinal cord injury

Therapeutic Effect of Curcumin and Methylprednisolone in the Rat Spinal Cord Injury.

Effect of Combined Treatment with Methylprednisolone and Nogo-A Monoclonal Antibody after Rat Spinal Cord Injury.

Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats

Effective Improvement of the Neuroprotective Activity after Spinal Cord Injury by Synergistic Effect of Glucocorticoid with Biodegradable Amphipathic Nanomicelles

Administration of High-Dose Methylprednisolone Worsens Bone Loss after Acute Spinal Cord Injury in Rats.

Natural Polyphenol Delivered Methylprednisolone Achieve Targeted Enrichment for Acute Spinal Cord Injury Therapy

Minocycline-Loaded Poly(-Lipoic Acid)-Methylprednisolone Prodrug Nanoparticles for the Combined Anti-Inflammatory Treatment of Spinal Cord Injury

Effect of high-dose methylprednisolone on expression of inducible nitric oxide synthase and apoptosis in rats after spinal cord injury

Synthesis of methylprednisolone loaded ibuprofen modified dextran based nanoparticles and their application for drug delivery in acute spinal cord injury

The experimental study of combined methylprednisolone and nimodipine in treatment of early spinal cord injury in rats

In Vivo Two-Photon Imaging of Axonal Dieback, Blood Flow and Calcium Influx Withmethylprednisolone Therapy after Spinal Cord Injury

Hyaluronic Acid-Coated Nanoparticles for the Localized Delivery of Methylprednisolone to the Injured Spinal Cord

Minocycline-Loaded Poly(α-Lipoic Acid)–Methylprednisolone Prodrug Nanoparticles for the Combined Anti-Inflammatory Treatment of Spinal Cord Injury

Preventive Effects of Large Dose Methylpednisolone on Neural Cell Apoptosis and Change of Basic Fibroblast Growth Factor in Rats after Acute Spinal Cord Injury